The Radiology Assistant : RECIST 1.1 - and more
CDISC Compliant Implementation of iRECIST and LYRIC for Immunomodulatory Therapy Trials
EPOS™
Assessing Immunotherapy Response and Progression
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics - The Lancet Oncology
CDISC Compliant Implementation of iRECIST and LYRIC for Immunomodulatory Therapy Trials
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics - ScienceDirect
PDF) Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: pooled FDA analysis
Novel oncologic therapy response criteria (iRECIST and more) - Mint Medical GmbH
ABSTRACT INTRODUCTION BACKGROUND AND HISTORY
How to better understand iRECIST – a new wave in immunotherapeutic
Statistical Analysis Plan Title: A Phase 1/2, Multicenter, Single-Arm, Open-Label, Dose-Escalation Study of Birinapant in Combin
Simplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies
Novel oncologic therapy response criteria (iRECIST and more) - Mint Medical GmbH
Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: pooled FDA analysis | Journal for ImmunoTherapy of Cancer
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics - The Lancet Oncology
iRECIST: how to do it | Cancer Imaging | Full Text
The Radiology Assistant : RECIST 1.1 - and more
Comparison of Radiological Tumor Response Based on iRECIST and RECIST 1.1 in Metastatic Clear-Cell Renal Cell Carcinoma Patient
Paper Template
Présentation PowerPoint
Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1, irRC, and iRECIST criteria: comparison with subjective assessment - Ying-Chieh Lai, Wen-Cheng Chang, Chun-Bing Chen, Chi-Liang Wang, Yu-Fen Lin, Ming-Mo Ho,
The Radiology Assistant : RECIST 1.1 - and more
RECIST 1.1 calculator - Radiology calculators
